Duke Cancer Institute

More nonsmoking women under the age of 50 are being diagnosed with lung cancer, raising alarm with oncologists. Laura Alder, MD spoke with WRAL about this trend and emphasized the need for heightened awareness. Read more: https://duke.is/g/xsmt #lungcancer Duke Health | Duke Department of Medicine

The 6th North Carolina Adolescent and Young Adult (AYA) Oncology Symposium will bring together multidisciplinary providers and researchers from across the state who are interested in improving care for this unique patient population. With a focus on survivorship care for the AYA population, this knowledge-based symposium will feature a mix of didactic lectures and panel discussions. Join us at the Westin Raleigh-Durham Airport on October 25! https://bit.ly/47W8wYB

Next Wednesday, the American Association for Cancer Research (AACR) will release the AACR Cancer Progress Report, which underscores how recent advances across the cancer care continuum, including immunotherapy and molecularly targeted therapies, are helping cancer patients and their loved ones. Michael Pignone, MD, MPH, director of DCI's Program on Cancer Screening Equity, will participate in a panel discussion of the ways we are addressing the needs of the rapidly expanding population of cancer survivors, as well as the disparities in cancer incidence, mortality, and access to care that still affect certain populations. Learn more and register to attend in person or view the livestream: https://lnkd.in/eUwZ87P4

Daniel George, MD, co-leader of the DCI Center for Prostate and Urologic Cancers, shared impressive results from a clinical trial for prostate cancer at #ASCO2024. The surprising results showed positive survival data for Black men with the disease. Dr. George received the IMPACT Research professorship from the American Cancer Society, designated for commitment to improving outcomes for all and eliminating disparities for Black men. The DCI Center for Prostate and Urologic Cancers is committed to tackling cancer disparities and has many more studies in progress to do just that. Learn more: https://bit.ly/3x9XIYK

Announcing Microbiome in Oncology Research Symposium Part 2, May 28, 2024 at #DukeCancerCenter in Duke South Amphitheater, 9 am - 3pm. Join us for exciting new research on bugs, drugs, and cancer. Breakfast/Lunch on us! #DukeMicrobiomeCenter #FindaCure #DCIcenterforProstateandUrologicCancers

People with bladder and other urothelial cancers got a long-awaited new FDA approved option in December that is already extending survival. Read the story of one patient's early access to pembro + padcev, thanks to the dedication of her medical team at Duke Cancer Institute. Looking ahead, Chris Hoimes, medical oncologist at DCI, leads #KeynoteB15, a global clinical trial of the drug combination in an earlier setting--before people undergo surgery. The trial has "curative intent," said Hoimes. #InnovativeTreatment | #CancerResearch | #Survival #Hope

Through palliative psychology, DCI's Katherine Ramos, PhD, and Laura Porter, PhD, are at the forefront of supporting patients in navigating the emotional complexities associated with illnesses like cancer and its impact on their lives. Duke Psychiatry & Behavioral Sciences | Duke University School of Medicine | Duke University Health System https://lnkd.in/ewAa8sF7

Proud of Dr. Moore and all the work that he and colleagues in the DCI Office of Health Equity do to bring research to the communities we serve. Duke University Health System

Thanks for sharing, Dr. Sullenger.

Thanks for sharing this very important work. Happy to have your participation!